Omada Health (NASDAQ: OMDA) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $873M. The Maz Rating grades it against the other companies in its sector.
Omada Health's current Maz Rating and its five factor grades are for members: log in to see them.
At $14.08, Omada Health trades at 59.2x trailing earnings, 2.6x sales and 3.2x book value, with an EV/EBITDA of 39.9. Over the last twelve months it generated about $333M of revenue and $15M of net income. It runs a gross margin of 70.7%, an operating margin of 2.1% and a net margin of 4.2%. It shows return on equity of 5.7%, return on invested capital of 2.5% and a free cash flow yield of 2.9%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 4.18. Over the past 52 weeks the share price ranged from $10.28 to $25.45, with a beta of 2.12.
Omada Health does not currently pay a dividend.
13 Wall Street analyst ratings cover the stock: 11 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Omada Health (OMDA) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 20.2% / 30% · Interest income / Revenue 2.18% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 20.2% / 33% · Receivables / Mkt Cap (36m) 4.01% / 49% · Interest income / Revenue 2.18% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 20.2% / 33.33% · Receivables / Mkt Cap (24m) 4.01% / 33.33% · Interest income / Revenue 2.18% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 0.00% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 69.9% / 33.33% · Receivables / Avg Assets (4Q) 14.0% / 33.33% · Interest income / Revenue 2.18% / 5% | Fail |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 69.8% / 33.33% · (Cash+Recv) / Total Assets 83.6% / 33.33% · Interest income / Revenue 2.18% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Omada Health (OMDA) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Omada Health is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 2.18% of each dividend: Omada Health's interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.